Top compounds associated with response to PRAMEF12


Feature Type Standardized
Nominal ANOVA
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.06 0.09
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.06 0.09
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.055 0.09
mRNA SNX-2112 GDSC1000 pan-cancer AAC 0.048 0.09
mRNA S-Trityl-L-cysteine GDSC1000 pan-cancer AAC -0.083 0.09
mRNA JQ-1 CTRPv2 pan-cancer AAC 0.052 0.09
mRNA thapsigargin gCSI pan-cancer AAC -0.09 0.09
mRNA AC220 GDSC1000 pan-cancer AAC 0.055 0.09
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC 0.06 0.1
mRNA alvocidib CTRPv2 pan-cancer AAC 0.081 0.1
Download CSV